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ABSTRACT
Background: The venous cannulation procedure was widely used in many
linical procedures; however, it is associated with pain or discomfort.
Objectives: The purpose of this study was to investigate whether transcuta-
neous electrical nerve stimulation (TENS) could reduce pain during cannulation of
vein.
Methods: One hundred patients were allocated randomly to 2 groups. In the
active TENS group, TENS was delivered via 2 electrodes on the venous cannulation
site (radial side of the wrist of dominant forearm) 20 minutes before venous cannu-
lation, and the control group received placebo (no current) TENS. Venous cannula-
tion with a 22-gauge cannula was performed. During venous cannulation, the pain
intensity (0  no pain, 10  worst pain imaginable) was measured. Any side effects
uring study periods were recorded.
Results: The incidence of pain during venous cannulation was similar between
he 2 groups. However, pain intensity was significantly lower in the active TENS
roup than placebo group (P  0.01). There was no significant difference in the side
ffects such as erythema and itching between the groups.
Conclusions: TENS may be a suitable option for reducing the pain intensity
uring venous cannulation. ClinicalTrials.gov identifier: NCT01607463. (Curr Ther Res
lin Exp. 2012;73:134–139) © 2012 Elsevier HS Journals, Inc. All rights reserved.
Key words: cannulation, pain, transcutaneous electrical nerve stimulation,
vein.
INTRODUCTION
The venous cannulation procedure was widely used in many clinical procedures.
However, it is associated with pain or discomfort. Consequently, the pain of venous
cannulation can increase stress and anxiety in some patients, which is often addressed
by the use of topical anesthesia.1 But intact skin presents a significant barrier to
Accepted for publication May 15, 2012. http://dx.doi.org/10.1016/j.curtheres.2012.05.001
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S. Kim et al.available topical anesthetic preparations. Therefore, many topical anesthetics must be
applied at least 45 to 60 minutes before the clinical procedure to achieve the desired
level of anesthesia. In addition, these topical anesthetic creams or gel-based prepa-
rations may require the use of occlusive dressings, adding to the time required for
their application.2 These factors can result in delays in performing the planned
rocedure.
Transcutaneous electrical nerve stimulation (TENS) is an established noninvasive
linical modality, which has been used for the symptomatic relief of acute and chronic
ain.3 Application of TENS segmentally to the pain site is commonly used in clinical
practice, depending on the condition to be treated and the individual patient
characteristics.4 Moreover, a good deal of physiologic evidence from stimulation
studies suggests that the most effective way to produce analgesia is by stimulating
peripheral nerves innervate the area from which pain originates.5
In the present study, we investigated whether TENS could have analgesic effect on
ain during venous cannulation.
METHODS
After receiving approval from the Ethics Committee of Kyungpook National Uni-
versity Hospital and written informed consent, 100 outpatients who underwent
plastic surgery were recruited in this randomized, single-masked, placebo-controlled
study. Exclusion criteria were concomitant sedative or analgesic medication and
neurological disease. In addition, we excluded all patients with potentially dangerous
internal diseases (American Society of Anesthesiologists physical status 3).
One hundred patients were allocated randomly to 2 groups: 2 electrodes (5  5
cm; TensCare) were attached to the radial side of dominant forearm and then active
or placebo TENS was delivered by an anesthesiologist who was aware of the group
allocation, using Select TENS units (Empi, St. Paul, Minnesota). The cephalic vein
was marked 1 cm proximal to radial styloid process, and the cathode was placed at
this point, whereas the anode was placed 3 cm away, more proximally. In the active
TENS group, TENS at 80 pulses per second (PPS) with a pulse duration of 200 sec
ere delivered for 20 minutes. Current amplitude was slowly increased until a level
as reached that participants reported was the maximum level that they could
olerate below their pain threshold without noticeable muscle contraction and main-
aining this intensity. In the placebo group, the TENS device had no current output,
lthough the power “on” indicator light remained active. Participants were told they
ay or may not feel a sensation during the intervention.
Twenty minutes after application of TENS, the electrodes were removed and
enous cannulation with a 22-gauge cannula was performed at the mark on the radial
ide of the wrist by the same nurse who was not involved in this study. The pain
ntensity during venous cannulation using a visual analog scale (VAS) from 0 to 10
0  no pain, 10  worst pain imaginable) was measured by a study-blinded
nesthesiologist. Any adverse effects during the study periods were recorded.
Data are presented as number (%) or mean (SD). Demographic data were analyzed
ith the Student t test. VAS scores during cannulation were compared using Wil-
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Current Therapeutic Researchcoxon rank sum test with continuity correction. Pain incidence and skin condition in
2 groups were compared using the 2 test or Fisher exact test. The SPSS software
version 14.0 (SPSS Inc, Chicago, Illinois) was used for statistical analysis. P  0.05
as considered as significant.
RESULTS
All participants were cannulated on the first attempt. The groups were similar with
regard to age, sex, height, and weight (Table I). The incidence of venous cannulation
pain was similar between 2 groups (P 0.05) (Table II). However, the pain intensity
ith active TENS (1.9 [1.2]) group was significantly lower than that with placebo
ENS (4.8 [1.5]) (P  0.01). There were no significant differences in the incidences
f side effects such as erythema and itching between the groups (P  0.05).
Table I. Demographic data.
Placebo TENS Group
(n  50)
Active TENS Group
(n  50)
Male, no. (%) 19 (38) 21 (42)
Female, no. (%) 31 (62) 29 (58)
Age, y (SD) 51.2 (11.7) 48.2 (13)
Height, cm (SD) 164.7 (8.5) 165.2 (7.8)
Weight, kg (SD) 59.93 (8.7) 61 (9.3)
TENS  transcutaneous electrical nerve stimulation.
There were no significant differences between groups.
Table II. Clinical outcomes.
Placebo TENS Group
(n  50)
Active TENS Group
(n  50)
Pain incidence, no. (%)
No pain 0 5 (10)
Pain 50 (100) 45 (90)
Pain intensity score on VAS (SD) 4.8 (1.5) 1.9 (1.2)*
Side effects, no. (%)
Erythema 5 (10) 7 (14)
Itching 2 (4) 1 (2)
TENS  transcutaneous electrical nerve stimulation; VAS  visual analog scale.
*P  0.01.
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Our results demonstrated that active TENS significantly reduced the pain intensity,
although it did not significantly decrease the pain occurrence during venous cannu-
lation compared with placebo TENS.
Pain during venous cannulation is unpleasant and often frightening for patients. In
fact, discomfort from the insertion of the venous catheter could be ranked fifth after
incisional pain, nausea, vomiting, and preoperative anxiety when anesthesiologists
judge the top 5 clinical anesthesia outcomes associated with ambulatory anesthesia.6
TENS is an acknowledged noninvasive clinical modality that has been used for the
management of painful conditions for 35 years.3 It could reduce postoperative
complications such as nausea, vomiting, acute pain, and chronic musculoskeletal pain
without adverse effects.7–10 However, the exact mechanism of action of TENS is still
largely unknown. It has been suggested that afferent activity produced by TENS
inhibits nociceptive transmission in the spinal cord through pre- as well as postsyn-
aptic inhibitory mechanisms.11
In the present study, TENS at 80 PPS was chosen because this was the recom-
ended potentially effective frequency for human studies.12–14 Low-frequency TENS
acts by -opioid receptors and 5-hydroxytryptamine receptors,15,16 whereas high-
frequency TENS acts by -opioid receptors and increasing -aminobutyric acid.17,18
In previous studies, high-frequency TENS at 80 PPS elevated pain threshold to
pressure algometry13 or reduced ischemic pain14 than low-frequency TENS at 3 PPS,
hen TENS intensity was strong but comfortable at the site of experimental pain.
onpainful impulse generation by TENS at 80 PPS would lead to stronger afferent
nput to the central nervous system, resulting in stronger inhibition of nociceptive
ransmission of second-order neurons, similar to the gate-control theory of pain.13,14
In the present study, the incidence of pain during venous cannulation was similar
between 2 groups. However, pain severity was significantly lower in the active TENS
group than the placebo TENS group. In addition, there was no significant difference
in the side effects such as erythema and itching. TENS is a simple and safe procedure.
The only limiting factors are patients with implanted electronic devices like pace-
makers, cardiac defibrillators, and spinal cord or deep brain stimulators.19 The veins
at the antecubital fossa, forearm, and wrist and at the dorsum of the hand that are
commonly used for venipuncture or cannulation are superficial to cutaneous nerves.
Therefore, repeated attempts at venipuncture or resulting hematomas can, although
rarely, cause nerve injury, which leads to the neuropathic pain syndrome.20 In the
present study, all participants were cannulated on the first attempt, and there were no
patients who reported any abnormal sensation such as paresthesia and burning
sensation.
CONCLUSIONS
Our study found that strong nonpainful TENS at 80 PPS significantly decreased pain
severity during venous cannulation compared with placebo TENS. Because of its ease
of use and lack of side effects, TENS may be a useful option to reduce pain during
venous cannulation.
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